FDA Inspection 1228886 — Michio Yagi
The FDA completed an inspection of Michio Yagi on Jan 25, 2024 in Osaka. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Osaka (Japan)
Additional Details
Clinical BA/BE